These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 3559228

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Fibrin fibrinogen degradation products and their significance in kidney diseases (literature review)].
    Peleshchuk AP, Belitskaia GA, Ena IaM, Drannik GN.
    Vrach Delo; 1979 Aug; (8):1-5. PubMed ID: 384672
    [No Abstract] [Full Text] [Related]

  • 3. [Acid-base metabolism in kdney diseases].
    Kaufmann W, Ilg R.
    Dtsch Med Wochenschr; 1968 Dec 27; 93(52):2520-5. PubMed ID: 5722754
    [No Abstract] [Full Text] [Related]

  • 4. [Protein supply in healthy subjects and subjects with kidney diseases].
    Gerhardt W.
    Z Arztl Fortbild (Jena); 1969 Mar 15; 63(6):317-22. PubMed ID: 5784072
    [No Abstract] [Full Text] [Related]

  • 5. [Change in the pharmacokinetics of drug substances in kidney diseases].
    Kudrin AN, Davydova ON, Androsova SO.
    Klin Med (Mosk); 1980 May 15; 58(5):13-6. PubMed ID: 6991802
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A study of protein clearances in patients with nephrotic syndrome.
    Dil AS, Naqvi SA, Jafarey NA.
    J Pak Med Assoc; 1976 Dec 15; 26(11):234-8. PubMed ID: 829357
    [Abstract] [Full Text] [Related]

  • 8. Renal clearance of 15 plasma proteins in renal disease.
    Bienenstock J, Poortmans J.
    J Lab Clin Med; 1970 Feb 15; 75(2):297-306. PubMed ID: 5461134
    [No Abstract] [Full Text] [Related]

  • 9. [The levels of antigens to plasminogen activators compared to their functional activity and inhibitor activity in patients with glomerulonephritis and amyloidosis].
    Bumblite ID, Poliantseva LR, Mukhin NA, Andreenko GV, Podorol'skaia LV, Liaginskiĭ AV, Varlamova NV.
    Ter Arkh; 1992 Feb 15; 64(11):52-6. PubMed ID: 1293845
    [No Abstract] [Full Text] [Related]

  • 10. Nutrition in renal disease.
    Richards P, Ell S.
    Hum Nutr Clin Nutr; 1982 Feb 15; 36(2):103-13. PubMed ID: 7050028
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Blood serum and urine levels of fibrin fibrinogen degradation products in kidney diseases].
    Kacprzyk F, Orłowski Z.
    Pol Tyg Lek; 1980 Mar 31; 35(13):461-3. PubMed ID: 7393746
    [No Abstract] [Full Text] [Related]

  • 13. Amylase to creatine clearance ratio in renal diseases.
    Andriulli A, Bergia R, Masoero G, Baiardi P, Pellegrino S, Tondolo M.
    Gastroenterology; 1979 Jul 31; 77(1):86-90. PubMed ID: 447031
    [Abstract] [Full Text] [Related]

  • 14. Cytostatic treatment of glomerular diseases. II. Effect of azathioprine on serum and urine proteins. Report from a Copenhagen Study Group of Renal Diseases.
    Balslov JT, Brun C, Jensen KB, Jorgensen F, Jorgensen HE, Larsen M, Lorenzen I, Thomsen AC.
    Acta Med Scand; 1973 Jun 31; 193(6):493-8. PubMed ID: 4721958
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.